Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Jun;7(6):836–839. doi: 10.1128/aac.7.6.836

In Vitro Susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to Trimethoprim and Trimethoprim-Sulfamethoxazole

Marcia R Moody 1, Viola M Young 1
PMCID: PMC429236  PMID: 1155926

Abstract

Our earlier studies had shown that the two pseudomonads, Pseudomonas cepacia and Pseudomonas maltophilia, were organisms that were highly resistant to most antibiotics. The present study was undertaken to determine the susceptibility of these bacteria to trimethoprim and the trimethoprim-sulfamethoxazole combination which has been used with apparent success in treating infections caused by these pseudomonads. All 51 strains of P. cepacia were inhibited by 2 μg or less of trimethoprim per ml, whereas all 45 of the P. maltophilia were resistant to greater than 32 μg/ml. When the P. maltophilia was tested against trimethoprim-sulfamethoxazole, two strains were resistant and one only moderately resistant, but all other strains were susceptible. All P. cepacia strains were also susceptible with an average zone of inhibition significantly larger than for P. maltophilia (P < 0.005). These in vitro studies support recent case study reports of successful therapy using the trimethoprim-sulfamethoxazole combination.

Full text

PDF
836

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassett D. C., Stokes K. J., Thomas W. R. Wound infection with Pseudomonas multivorans. A water-borne contaminant of disinfectant solutions. Lancet. 1970 Jun 6;1(7658):1188–1191. doi: 10.1016/s0140-6736(70)91783-6. [DOI] [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Dailey R. H., Benner E. J. Necrotizing pneumonicitis due to the pseudomonad "eugonic oxidizer--group I". N Engl J Med. 1968 Aug 15;279(7):361–362. doi: 10.1056/NEJM196808152790706. [DOI] [PubMed] [Google Scholar]
  4. Ederer G. M., Matsen J. M. Colonization and infection with Pseudomonas cepacia. J Infect Dis. 1972 Jun;125(6):613–618. doi: 10.1093/infdis/125.6.613. [DOI] [PubMed] [Google Scholar]
  5. Fischer J. J. Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study. J Infect Dis. 1973 Nov;128(Suppl):771–773. doi: 10.1093/infdis/128.supplement_3.s771. [DOI] [PubMed] [Google Scholar]
  6. Gardner P., Griffin W. B., Swartz M. N., Kunz L. J. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med. 1970 Jun;48(6):735–749. doi: 10.1016/s0002-9343(70)80009-2. [DOI] [PubMed] [Google Scholar]
  7. Gilardi G. L. Characterization of EO-1 strains (Pseudomonas kingii) isolated from clinical specimens and the hospital environment. Appl Microbiol. 1970 Sep;20(3):521–522. doi: 10.1128/am.20.3.521-522.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilardi G. L. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med. 1972 Aug;77(2):211–215. doi: 10.7326/0003-4819-77-2-211. [DOI] [PubMed] [Google Scholar]
  9. Gilardi G. L. Pseudomonas maltophilia infections in man. Am J Clin Pathol. 1969 Jan;51(1):58–61. doi: 10.1093/ajcp/51.1.58. [DOI] [PubMed] [Google Scholar]
  10. Moffet H. L., Allan D., Williams T. Survival and dissemination of bacteria in nebulizers and incubators. Am J Dis Child. 1967 Jul;114(1):13–20. doi: 10.1001/archpedi.1967.02090220019003. [DOI] [PubMed] [Google Scholar]
  11. Moffet H. L., Williams T. Bacteria recovered from distilled water and inhalation therapy equipment. Am J Dis Child. 1967 Jul;114(1):7–12. doi: 10.1001/archpedi.1967.02090220013002. [DOI] [PubMed] [Google Scholar]
  12. Moody M. R., Young V. M., Kenton D. M. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother. 1972 Nov;2(5):344–349. doi: 10.1128/aac.2.5.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Neu H. C., Garvey G. J., Beach M. P. Successful treatment of Pseudomonas cepacia endocarditis in a heroin addict with trimethoprim-sulfamethoxazole. J Infect Dis. 1973 Nov;128(Suppl):768–p. doi: 10.1093/infdis/128.supplement_3.s768. [DOI] [PubMed] [Google Scholar]
  14. Nord C. E., Wadström T., Wretlind B. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother. 1974 Oct;6(4):521–523. doi: 10.1128/aac.6.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pedersen M. M., Marso E., Pickett M. J. Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol. 1970 Aug;54(2):178–192. doi: 10.1093/ajcp/54.2.178. [DOI] [PubMed] [Google Scholar]
  16. Phillips I., Eykyn S., Curtis M. A., Snell J. J. Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit. Lancet. 1971 Feb 20;1(7695):375–377. doi: 10.1016/s0140-6736(71)92212-4. [DOI] [PubMed] [Google Scholar]
  17. Pickett M. J., Pedersen M. M. Characterization of saccharolytic nonfermentative bacteria associated with man. Can J Microbiol. 1970 May;16(5):351–362. doi: 10.1139/m70-062. [DOI] [PubMed] [Google Scholar]
  18. Stanier R. Y., Palleroni N. J., Doudoroff M. The aerobic pseudomonads: a taxonomic study. J Gen Microbiol. 1966 May;43(2):159–271. doi: 10.1099/00221287-43-2-159. [DOI] [PubMed] [Google Scholar]
  19. Yabuuchi E., Miyajima N., Hotta H., Oyama A., Tanaka N. Pseudomonas cepacia from blood of a burn patient. Med J Osaka Univ. 1970 Dec;21(1):1–6. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES